James S. McGinley, Ph.D.
Affiliations: | 2014 | Psychology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Psychometrics PsychologyGoogle:
"James McGinley"Mean distance: 24.62 (cluster 26)
Parents
Sign in to add mentorPatrick J. Curran | grad student | 2014 | UNC Chapel Hill | |
(A novel mixed effects modeling framework for longitudinal ordinal substance use data.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Houts CR, McGinley JS, Wirth RJ, et al. (2020) Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation |
Houts CR, Wirth RJ, McGinley JS, et al. (2020) Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic Migraine. Headache |
Houts CR, Wirth RJ, McGinley JS, et al. (2019) Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative Review. Headache |
McGinley JS, Buse DC, Shulman KJ, et al. (2019) Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial. Headache |
McGinley JS, Wirth RJ, Houts CR. (2019) Growth Curves for Headache Research: A Multilevel Modeling Perspective. Headache |
Schenkel EJ, Messina JC, Bodine A, et al. (2018) Disease Burden of Chronic Rhinosinusitis (CRS) is as Severe as Other Serious Chronic Diseases Journal of Allergy and Clinical Immunology. 141: AB165 |
Burns AR, Hussong AM, Solis JM, et al. (2017) Examining Cohort Effects in Developmental Trajectories of Substance Use. International Journal of Behavioral Development. 41: 621-631 |
Lipton RB, McGinley JS, Shulman KJ, et al. (2017) AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial. Headache |
Lipton RB, McGinley JS, Shulman KJ, et al. (2017) Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study. Headache |
McGinley JS, Curran PJ, Hedeker D. (2015) A novel modeling framework for ordinal data defined by collapsed counts. Statistics in Medicine. 34: 2312-24 |